In GC, IL‐8 secreted by CAFs activates the NF‐kB pathway, upregulating PD‐L1 expression in tumor cells and attenuating the cytotoxicity of CD8+ T cells, thereby promoting GC progression [167]. The gene discussed is CD8A; the disease is neoplasm.